Stephen Morlock

Stephen Morlock appears in our data through filings on Timber Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 5 filings cover trades dated from 7 January 2016 to 14 January 2016.

Purchases make up the whole of the open-market record (5 purchases). No amount is published for 5 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 15 January 2016, reports an open-market purchase in Timber Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.